These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 27636542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT, N'gbesso YK, Knopp S, Keiser J, N'Goran EK, Utzinger J.
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A, Lamine MS, Barkiré N, Djibo A, Sofo B, Gouvras AN, Labbo R, Sebangou H, Webster JP, Fenwick A, Utzinger J.
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO, Rawago FO, Makworo NK, Muok EMO.
    Parasit Vectors; 2024 Jun 28; 17(1):279. PubMed ID: 38943214
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J, N'Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, Hatz C, Utzinger J, N'Goran EK.
    Clin Infect Dis; 2010 May 01; 50(9):1205-13. PubMed ID: 20350194
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A, Lamine MS, Djibo A, Tahirou A, Aouami MA, Alfari A, Phillips AE, Fenwick A, Utzinger J.
    Acta Trop; 2013 Nov 01; 128(2):318-25. PubMed ID: 23237719
    [Abstract] [Full Text] [Related]

  • 7. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.
    Acta Trop; 2013 Nov 01; 128(2):292-302. PubMed ID: 23022016
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA, Momo SC, Stothard JR, Rollinson D.
    Acta Trop; 2013 Nov 01; 128(2):275-83. PubMed ID: 23791803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
    Barda B, Coulibaly JT, Hatz C, Keiser J.
    PLoS Negl Trop Dis; 2017 Feb 01; 11(2):e0005400. PubMed ID: 28222149
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P, Murare HM, Manomano K.
    J Trop Med Hyg; 1988 Feb 01; 91(1):13-7. PubMed ID: 3126306
    [Abstract] [Full Text] [Related]

  • 12. Bayesian risk mapping and model-based estimation of Schistosoma haematobium-Schistosoma mansoni co-distribution in Côte d'Ivoire.
    Chammartin F, Houngbedji CA, Hürlimann E, Yapi RB, Silué KD, Soro G, Kouamé FN, N Goran EK, Utzinger J, Raso G, Vounatsou P.
    PLoS Negl Trop Dis; 2014 Dec 01; 8(12):e3407. PubMed ID: 25522007
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
    Hoekstra PT, Casacuberta-Partal M, van Lieshout L, Corstjens PLAM, Tsonaka R, Assaré RK, Silué KD, Meité A, N'Goran EK, N'Gbesso YK, Amoah AS, Roestenberg M, Knopp S, Utzinger J, Coulibaly JT, van Dam GJ.
    PLoS Negl Trop Dis; 2020 Mar 01; 14(3):e0008189. PubMed ID: 32196506
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
    Coulibaly JT, Panic G, Yapi RB, Kovač J, Barda B, N'Gbesso YK, Hattendorf J, Keiser J.
    BMC Med; 2018 Jun 01; 16(1):81. PubMed ID: 29855373
    [Abstract] [Full Text] [Related]

  • 15. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial.
    N'Goran EK, Odiere MR, Assandé Aka R, Ouattara M, Aka NAD, Ogutu B, Rawago F, Bagchus WM, Bödding M, Kourany-Lefoll E, Tappert A, Yin X, Bezuidenhout D, Badenhorst H, Huber E, Dälken B, Haj-Ali Saflo O.
    Lancet Infect Dis; 2023 Jul 01; 23(7):867-876. PubMed ID: 36893784
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT, Casacuberta Partal M, Amoah AS, van Lieshout L, Corstjens PLAM, Tsonaka S, Assaré RK, Silué KD, Meité A, N'Goran EK, N'Gbesso YK, Roestenberg M, Knopp S, Utzinger J, Coulibaly JT, van Dam GJ.
    BMC Infect Dis; 2018 Dec 14; 18(1):662. PubMed ID: 30547750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
    Olliaro PL, Coulibaly JT, Garba A, Halleux C, Keiser J, King CH, Mutapi F, N'Goran EK, Raso G, Scherrer AU, Sousa-Figueiredo JC, Stete K, Utzinger J, Vaillant MT.
    PLoS Negl Trop Dis; 2020 Jun 14; 14(6):e0008277. PubMed ID: 32569275
    [Abstract] [Full Text] [Related]

  • 20. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
    Keiser J, Silué KD, Adiossan LK, N'Guessan NA, Monsan N, Utzinger J, N'Goran EK.
    PLoS Negl Trop Dis; 2014 Jul 14; 8(7):e2975. PubMed ID: 25033291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.